AKT1 and breast carcinoma: The phosphatidylinositol-3-kinase (PI3K)/Akt (also known as protein kinase B) pathway has been demonstrated to be dysregulated in many types of cancer, including breast cancer [12], and to be associated with poor prognosis [13,14].